Zydus Lifesciences Ltd.

US Food and Drug Administration (USFDA) has concluded Pre-Approval Inspection (PAI) for Injectable Medical Devices at Zydus Lifesciences’ unit 9 facility located at Zydus Biotech Park, Changodar, Ahmedabad. The inspection was conducted from February 16, 2026 to February 19, 2026.  The inspection closed with Nil observations. 

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.